Neuro-Oncology News

A small-molecule chemotherapeutic did not improve efficacy compared with standard therapies in adults with glioblastoma, according to the manufacturer.

The FDA announced several regulatory actions.

An implantable microdevice designed to test treatments in patients with gliomas during standard-of-care surgery has been easily and safely incorporated into surgical practice.

An estimated 10% to 40% of patients with solid tumors develop brain metastases.

A novel oncolytic virus gene therapy extended survival among a small cohort of patients with high-grade glioblastoma, according to study results published in Nature.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Researchers at Salk Institute for Biological Studies have achieved promising results in early studies using an anti-CTLA-4 antibody for treatment of glioblastoma, the most common and deadliest form of brain cancer.

The FDA announced several regulatory actions.

The FDA expanded use of Temodar to include two new indications for the treatment of adults with anaplastic astrocytoma.

Results from the American Association for Cancer Research’s annual Cancer Progress Report revealed that the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2020.